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Conserved and species-specific molecular denominators in
mammalian skeletal muscle aging
Evi M. Mercken1, Miriam Capri2,3, Bethany A. Carboneau1, Maria Conte2,3, Juliana Heidler4, Aurelia Santoro 2,3, Alejandro
Martin-Montalvo1, Marta Gonzalez-Freire1, Husam Khraiwesh5, José A. González-Reyes5, Ruin Moaddel6, Yongqing Zhang7,
Kevin G. Becker7, José M. Villalba5, Julie A. Mattison8, Ilka Wittig4,9, Claudio Franceschi10 and Rafael de Cabo 1
Aging is a complex phenomenon involving functional decline in multiple physiological systems. We undertook a comparative
analysis of skeletal muscle from four different species, i.e. mice, rats, rhesus monkeys, and humans, at three different representative
stages during their lifespan (young, middle, and old) to identify pathways that modulate function and healthspan. Gene expression
profiling and computational analysis revealed that pathway complexity increases from mice to humans, and as mammals age, there
is predominantly an upregulation of pathways in all species. Two downregulated pathways, the electron transport chain and
oxidative phosphorylation, were common among all four species in response to aging. Quantitative PCR, biochemical analysis,
mitochondrial DNA measurements, and electron microscopy revealed a conserved age-dependent decrease in mitochondrial
content, and a reduction in oxidative phosphorylation complexes in monkeys and humans. Western blot analysis of key proteins in
mitochondrial biogenesis discovered that (i) an imbalance toward mitochondrial fusion occurs in aged skeletal muscle and (ii)
mitophagy is not overtly affected, presumably leading to the observed accumulation of abnormally large, damaged mitochondria
with age. Select transcript expression analysis uncovered that the skeletal inflammatory profile differentially increases with age, but
is most pronounced in humans, while increased oxidative stress (as assessed by protein carbonyl adducts and 4-hydroxynonenal) is
common among all species. Expression studies also found that there is unique dysregulation of the nutrient sensing pathways
among the different species with age. The identification of conserved pathways indicates common molecular mechanisms intrinsic
to health and lifespan, whereas the recognition of species-specific pathways emphasizes the importance of human studies for
devising optimal therapeutic modalities to slow the aging process.
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INTRODUCTION
Aging is a complex and inevitable phenomenon that almost
certainly involves the gradual accumulation of damage to the
cellular machinery, eventually leading to the progressive dete-
rioration of normal biological functions, and an increased risk of
disease and death.1 One of the hallmarks of aging is a marked
decline in human skeletal muscle mass and strength, commonly
referred to as sarcopenia.2 Indeed, sarcopenia has been observed
across a wide variety of species, including worms, flies, rodents
and primates.3–5 Sarcopenia is a multifactorial condition involving
many potential mechanisms, such as an altered hormonal status
(decreased levels of testosterone, androgen), inefficient protein
synthesis, satellite cell dysfunction, muscle denervation, and
altered neuromuscular junction integrity. Some of the key
processes thought to muscle loss include mitochondrial dysfunc-
tion, oxidative stress, chronic inflammation, and perturbations to
the insulin-like-growth factor (IGF-1) and the mechanistic target of
rapamycin (mTOR) signaling pathways.6, 7
Mitochondria are considered the powerhouse of the cell, and
use oxygen to generate energy in the form of ATP, creating
reactive oxygen species (ROS) as by-products in this process.
Importantly, these organelles are highly dynamic, exhibiting the
ability to carry out fission and fusion.8 The former allows
mitochondria to transmit among dividing cells, meet increased
ATP demands, and maintain mitochondrial quality, primarily
through autophagy.9, 10 Fusion is the counterpart biological event,
and involves the mixture of mitochondrial compartments to (i)
preserve the equilibrium of oxidative phosphorylation (OXPHOS)
proteins critical to respiration, (ii) carry out energy exchange, and
(iii) complement defects in the mitochondrial genome.11, 12
Additionally, it has been uncovered that mitochondrial electron
transport chain (ETC) components can exist as supercomplexes,
facilitating the electron flow, and hence making the system more
efficient.13, 14 Destabilization of the supramolecular organization
may contribute to the development of an aging phenotype, as it
has been shown that a lack of supercomplex formation leads to
mitochondrial activity impairment, and reduced ATP levels.15
Received: 8 September 2016 Revised: 9 January 2017 Accepted: 21 March 2017
1Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, 251 Bayview Boulevard, Baltimore, MD 21224, USA; 2Department of Experimental,
Diagnostic and Specialty Medicine (DIMES), University of Bologna, 40126 Bologna, Italy; 3Interdepartmental Centre “L. Galvani” (CIG), University of Bologna, 40126 Bologna, Italy;
4Functional Proteomics, SFB815 Core Unit, Cluster of Excellence Frankfurt “Macromolecular Complexes,” Goethe-University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main,
Germany; 5Departamento de Biología Celular, Fisiología e Inmunología, Universidad de Córdoba, Campus de Excelencia Internacional Agroalimentario ceiA3, Campus Rabanales
Edificio Severo Ochoa, 3ª planta, 14014 Córdoba, Spain; 6Bioanalytical and Drug Development Unit, National institute on Aging, National Institutes of Health, 251 Bayview
Boulevard, Baltimore, MD 21224, USA; 7Gene Expression and Genomics Unit, National Institute on Aging, National Institutes of Health, 251 Bayview Boulevard, Baltimore, MD
21224, USA; 8Translational Gerontology Branch, National Institute on Aging, Intramural Research Program, Poolesville, MD 20837, USA; 9German Center of Cardiovascular
Research (DZHK), Partner site RheinMain, Frankfurt, Germany and 10IRCCS, Institute of Neurological Sciences of Bologna, 40139 Bologna, Italy
Correspondence: Rafael de Cabo (DECABORA@MAIL.NIH.GOV)
www.nature.com/npjamd
Published in partnership with the Japanese Society of Anti-Aging Medicine
In many studies, age-dependent mitochondrial dysfunction has
been reported to drive life-threatening disorders, such as frailty,
and accelerate the aging process.16, 17 Recent reviews by Nair and
others18–20 have highlighted the specific involvement in human
sarcopenia of reduced mitochondrial DNA (mtDNA) and protein
content, impaired enzymatic activity and elevated markers of
oxidative damage. However, a report by Lustgarten et al.21 found
that oxidative stress, introduced by deletion of the radical
scavenger MnSOD in mice, resulted in mitochondrial impairment,
but not muscle atrophy during aging. Thus, the molecular
choreography between mitochondria and aging is multi-factorial
and requires further investigation.
Often associated with defects in mitochondrial function is
oxidative stress. Elevated levels of ROS can lead to increased
macromolecular damage, namely to lipids, proteins and nucleic
acids, which in turn can promote cellular dysfunction and
organismal aging. Although the free radical theory of aging has
experienced its setbacks, there is still significant evidence
indicating an age-dependent accumulation of oxidative modifica-
tions in the main cellular components in skeletal muscle.22
Nevertheless, a revised look at this theory has suggested that
harmful imbalances in redox homeostasis or signaling may be
more central to the aging phenomenon than to the oxidative
damage itself.23
Another major etiological event in aging muscle is low-grade
chronic inflammation, or the so-called inflamm-aging phenom-
enon.24 The inflammatory response is also a common denomi-
nator of major diseases such as diabetes, obesity and cancer.25
This event has been proposed to arise due to an overall condition
of oxidative stress, which activates signaling pathways, such as the
nuclear factor-κB-driven (NF-κB) transcriptional response. The
resulting production of pro-inflammatory cytokines and ROS
further augment this perturbed oxidative redox state, leading to
a vicious cycle.
The nutrient-sensing insulin/IGF-1/mTOR pathway is a highly
conserved pathway in evolution that is involved in the regulation
of cell growth, survival, and energy metabolism.26 The kinase Akt
plays an important role in this pathway, as Akt stimulates (i)
protein synthesis by activating the kinase mTOR and glycogen
synthase kinase 3β (GSK-3β) and (ii) protein degradation by
repressing the transcription factor FoxO.7, 27 This insulin/IGF-1/
mTOR network also plays a complex role in the aging process. In
the case of muscle growth, the pathway is activated, whereas
reduced signaling has been associated with longevity, both in
humans and model organisms.28
While the above processes all have supporting evidence for
their involvement in the aging phenomenon, there are also
reports that have raised questions about their participation in this
process. To attempt to consolidate the current picture regarding
skeletal muscle aging, we have analyzed four distinct species with
vastly different lifespans, i.e., humans, monkeys, rats and mice, to
identify genetic pathways that are commonly regulated. Con-
served pathways are of specific interest because they may reveal
molecular mechanisms intrinsic to aging, which ultimately play a
major role in modulating human health and lifespan. A particular
strength of this study is the inclusion of multiple age-groups
that span the comparative life stages across species, and the
involvement of an advanced-age group, which allows for the
detection of gradually changing molecular events and those that
occur strictly later in life.
RESULTS
Age-related differences in body composition among species
Aging has been associated with alterations in body composition
in various species, including humans, and such changes can
promote adverse health outcomes and retard successful aging.
We determined the effects of aging on bodyweight and body
composition across four different species—C57Bl/6J male mice,
Fischer 344 male rats, male rhesus monkeys, and male humans—
at three different ages chosen to represent similar stages during
their respective lifespans (see below), broadly defined as young,
middle-aged and old (Table 1). All species were heavier at middle
and old age compared to their young counterparts, although no
significant difference in bodyweight was observed for humans
between the middle and old age classifications (Table 1). We note
that in humans one individual was an outlier for these parameters,
and excluding that participant from the analysis indicates a
statistically significant difference, similar to what is seen for mice,
rats and monkeys, i.e., higher weight at middle and old age
relative to young.
Contrary to our expectations, middle-aged mice had higher
percentage fat mass and lower percentage muscle mass
compared to young mice, whereas old mice exhibited lower
percentage fat mass and higher percentage lean mass (Table 1).
However, when lean mass was not normalized to bodyweight, a
significant decrease in lean mass was observed in old mice
compared to young (20.3 g ± 1.23 young vs. 18.94 g ± 0.83 old). In
agreement with these data, wet mass of hindlimb muscles (soleus,
plantaris, gastrocnemius, tibialis, and extensor digitorumlongus)
were lighter in old mice compared to young (Fig. S1). In rats, our
data indicate that fat mass increases with age, while lean mass
decreases. A similar pattern is observed for rhesus monkeys,
comparing middle and old aged animals, and for humans, as
measured by muscle thickness (Table 1). Consistent with previous
studies,16, 29–31 our results show that muscle mass among all
species declines with age (Table 1). Most striking was the fat mass
distribution between mice as compared to rats, rhesus monkeys,
and humans; old mice have lower fat mass compared to their
younger counterparts (Table 1). Therefore, in terms of body
composition, humans seem to be most closely related to their
nearest evolutionary counterparts.
Common signature across species indicative of disruptive
mitochondrial homeostasis
Next, we determined whether age modifies the gene expression
profile in skeletal muscle of mice, rats, and rhesus monkeys in a
pattern similar to what is observed in humans. We emphasize
again that the three age groups selected (young, middle, and old)
fall at similar time points along the lifespan curves of each
organism (Fig. 1a, b). Principle component analysis (PCA) revealed
a very distinct separation of the three age groups among each
species for genes (Fig. 1c) and pathways (Fig. 1d). Notably, young
animals/humans are more closely related to their middle-aged
counterparts than to old individuals, and this pattern is consistent
among all species studied. The pattern is also consistent with the
idea that young and middle-aged groups fall closer to each other
on the lifespan trajectory than the middle-aged and old groups
(Fig. 1a, b).
To further define the role of age in modifying skeletal muscle
gene expression in diverse species, we performed parametric
analysis of gene set enrichment (PAGE), a computational method
that determines differences between genes and pathways using a
priori defined gene sets.32 PAGE analysis revealed that as one
moves from mice to humans, pathway complexity increases, and
as mammals age, there is predominantly an upregulation of
pathways in all species (Fig. 1e, and Table S2). Furthermore, this
analysis indicates that aging leads to perturbations in pathways
associated with energy metabolism (i.e., oxidative phosphoryla-
tion, glucose, and fatty acid metabolism), diabetes (synthesis and
function of insulin, IGF, and ghrelin), immune response and
protein synthesis (Table S3). Our transcriptional profiling also
revealed an age-induced increase in the inflammatory response
(a list of the top 20 up and downregulated inflammatory genes
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can be found in Table S4). Notably, only two downregulated
pathways, ETC and OXPHOS, were common among all four species
in response to aging (Fig. 1f, and Table S5). To define the
interacting networks and canonical pathways that are associated
with muscle aging, ingenuity pathway analysis (IPA) was
performed. IPA identified multiple genes encoding various
canonical signaling pathways that were modulated by age,
including mitochondrial dysfunction and the IGF-1/mTOR signal-
ing pathways (Figs. S2–S4 from A–D). Collectively, our array data
and subsequent analysis identify the highly conserved pathways
of mitochondrial function, inflammatory responses, and nutrient
sensing networks as common denominators of aging.
Aging leads to altered mitochondrial composition
To gain insights into the molecular events underlying the putative
mitochondrial dysfunction, we examined the effects of aging on
mitochondrial content in skeletal muscle. The protein complexes
of the OXPHOS system are encoded by the mitochondrial and
nuclear genomes, and a coordinated control of these two
genomes is required to maintain mitochondrial integrity. Quanti-
tative PCR of a number of nuclear-encoded and mitochondrial-
encoded transcripts revealed that the former are largely
unchanged between young, middle-aged, and old mouse samples
(Fig. 2a–c). Conversely, analysis of the mtDNA encoded genes
indicated a general trend of reduced expression in the old mouse
samples, which was statistically significant in 8 of 12 genes
examined (Fig. 2a–c). In rhesus monkeys, an overall down-
regulation of both nuclear and mitochondrial-encoded OXPHOS
messenger RNAs (mRNAs) was observed with age (Fig. 2d–f).
Notably, in humans, expression of mitochondrial and nuclear-
encoded transcripts decreased with age (Figs. 2g–i), even if a
major preservation of gene transcription level in mitochondria
than nucleus was found at least until middle age. Importantly, this
is one of the major differences comparing different species in
terms of mitochondrial transcripts.
To specifically assess the influence of age on markers of
mitochondrial content in skeletal muscle, three different
approaches were taken. First, we measured citrate synthase
activity, an enzyme found in the mitochondrial matrix, and
observed that this activity was significantly lower in the skeletal
muscle of aged mice and monkeys compared to their younger
counterparts (Fig. 2j). In humans, lower levels of citrate synthase
activity were observed in middle-aged individuals as compared to
young, yet no differences were observed between young and old
participants (Fig. 2j). Second, we quantified mtDNA, which was
found to be lower in the skeletal muscle of aged mice and
humans, although this finding was not recapitulated in monkeys
(Fig. 2k). Third, electron microscopy revealed that the mitochon-
drial size increased with age in the skeletal muscle of mice, in
accordance with prior work,33 while in monkeys, mitochondrial
size increased at middle-age, before decreasing in the old animals
(Fig. 2l, m). Notably, during aging, a difference in the shape of
mitochondria was observed in both aged mice and rhesus
monkeys (Fig. 2l, m). Whereas the mitochondria were less rounded
in old muscle of mice, a significant proportion of the organelles
were more rounded in shape in the muscle of old monkeys (Fig. 2l,
m). Although electron microscopy analysis was unable to be
Table 1. Study characteristics
Mice Rats Rhesus Humans
Young n 5 5 6 5
Age (m/y) 5 month 5 month 6.00± 0.00 years 31.2± 0.86 years
Height, cm – – – 173.4± 4.0
BW (g/kg) 29.93± 0.85 243.1± 8.2 8.50± 0.21 78.40± 7.28
BMI (kg/m2) – – – 25.86± 2.23
Fat mass (%) 19.61± 0.93 25.00± 0.22 20.13± 4.65 –
Lean mass (%) 59.44± 0.39 65.70± 0.21 79.87± 4.64 –
MT (cm) – – – 1.91± 0.08
Middle n 5 5 6 4
Age (m/y) 17 months 17 months 16.48± 0.31 years 46.0± 0.71 years
Height (cm) – – – 176.2± 2.2
BW (g/kg) 41.67± 2.11* 401.0± 14.6* 13.31± 0.33* 87.50± 7.15
BMI (kg/m2) – – – 28.28± 1.91
Fat mass (%) 24.30± 0.57* 30.68± 0.31* 21.07± 6.68 –
Lean mass (%) 58.25± 0.17* 61.04± 0.33* 78.92± 6.68 –
MT (cm) – – – 1.71± 0.09
Old n 5 5 6 7
Age (m/y) 28 months 30 months 26.83± 0.22 years 74.0± 4.38 years
Height (cm) – – – 169.9± 2.2
BW (g/kg) 46.55± 7.30* 417.1± 15.7* 11.12± 0.68* 85.86± 3.16
BMI (kg/m2) – – – 29.74± 0.99
Fat mass (%) 13.76± 0.36* 30.41± 0.31* 19.43± 5.23 –
Lean mass (%) 60.91± 0.18* 61.19± 0.32* 70.32± 11.4 –
MT (cm) – – – 1.35± 0.13*
Values are mean± SEM. Fat mass and lean mass data from mice (young: n= 20, middle: n= 15, old: n= 11), rats (young: n = 29, middle: n= 27, old: n = 21),
monkeys (young: n= 6, middle: n = 6, old: n = 3)
m/y months/years, BW body weight, BMI body mass index, MT muscle thickness
*p< 0.05 compared to young
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Fig. 1 Identification of disrupted mitochondrial homeostasis as a common age-related signature across species. Mean and maximum lifespan
curves for mice and rats (a), and rhesus monkeys and humans (b). Data were taken from the following references: mice mean76 and
maximum77 lifespan, rat mean78 and maxium78 lifespan, rhesus mean79 and maximum79 lifespan and human mean (https://www.nia.nih.gov/
research/publication/global-health-and-aging/living-longer) and maximum80 lifespan. Black squares represent mean and maximum lifespan,
whereas red, green, and blue squares stand for young, middle-aged, and old species, respectively. PCA analysis from c genes and d pathways of
mice, rats, rhesus monkeys, and humans of different ages are shown in red (Y, young), green (M, middle-aged), and blue (O, old). e Parametric
analysis of gene-set enrichment (PAGE) was performed on micro-array data from different species. Columns show every gene set significantly
upregulated (red) or downregulated (blue) by age. f Venn diagrams showing the up and downregulated gene set interactions between the
different species and ages. Full names and Z-ratios for each of the gene set represented in the Venn diagrams are presented in the
supplemental material (Table S5)
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performed in humans due to limited material, previous studies
have revealed that a significant proportion of mitochondria are
abnormally enlarged and more rounded in shape.34, 35 Thus,
despite the instances of variability, the overall picture indicates an
altered expression or organization of mitochondrial components
with age. Consistent with this conclusion, and in agreement with a
previous study that showed a reduced mitochondrial ATP
production in skeletal muscle of old healthy individuals,36 cellular
ATP levels tended to be decreased in the skeletal muscle of old
monkeys compared to their younger counterparts, whereas this
was not seen in old mice (Fig. 2n). Thus, the results collectively
indicate a conserved evolutionary age-dependent decrease in
mitochondrial content and function.
Aged skeletal muscle displays a decrease in OXPHOS complexes in
primates
In mammalian mitochondria, the respiratory chain supercom-
plexes form ‘‘respirasomes’’ structures, which mainly comprise
complexes I assembled to complex III and IV.14, 37 To elucidate
whether aging alters structural organization of the respiratory
chain, the composition of the different OXPHOS complexes in
skeletal muscle lysates from rats, rhesus monkeys and humans
was analyzed by blue native gel electrophoresis (BNE) in
combination with in-gel activity using digitonin for solubilization,
as this retains inner mitochondrial membrane supercomplexes
(Figs. 3–5).14 Figure 3a shows the five OXPHOS complexes as well
as the supercomplex S in the skeletal muscle of rats. No
differences in the content of ETC complexes were observed in
rat skeletal muscle upon age (Fig. 3b and Fig. S5A–F). However,
unlike rats, coomassie- or silver-staining and subsequent densito-
metric analysis showed a combined age-related OXPHOS altera-
tion in skeletal muscle of monkeys, with significantly lower
amounts of complex V (Fig. 4a left panel, + b, d–e and Fig. S6A–F).
Densitometric analysis also revealed a tendency towards reduced
levels of the supercomplex S in the old monkeys, indicative of less
effective electron transport with age (Fig. 4b + d–e and Fig. S7).38
Additionally, an in-gel activity assay suggested a downregulation
of complex I with age in muscle lysates of monkeys (Fig. 4a right
panel + c, and Fig. S7), in line with the tendency for reduced
supercomplex formation, as the presence of respirasomes is
necessary for the stability and function of complex I. Cardiolipin, a
phospholipid specific to the inner mitochondrial membrane, can
also integrate into the structure of the respiratory complexes and
aids in binding the complexes together into a supercomplex.39
A preliminary method was carried out to determine the ratio of
tetra linoleoyl cardiolipin to tri-linoleoyl-mono-oleoyl cardiolipin
(L4/L3O), the two most abundant cardiolipin species in muscle
tissue, in subsarcolemmal and intermyofibrillar mitochondria in
young and old monkeys. While, the data is not quantitative, the
preliminary results suggest that the L4/L3O ratio trends lower in
aged skeletal muscle (Fig. 4f). Although no significance was
reached for the different complexes (supercomplex S, III, IV, V) in
the skeletal muscle of humans due to the high degree of sample
variability, the amount of all OXPHOS complexes was reduced
with age (Fig. 5a, b and Fig. S8A–E). The above data show a
commonality between rhesus monkeys and humans, indicating a
reduction in OXPHOS complexes with age, an observation that is
consistent with the IPA (Fig. S2A–D).
Aging underlies altered mitochondrial dynamics and mitophagy
Mitochondria are highly dynamic organelles, constantly under-
going cycles of fusion, fission and mitophagy in order to meet the
bioenergetic requirements of the cell. Perturbations in mitochon-
drial dynamics precede cellular dysfunction and have been
implicated in the progression of age-related diseases such as
sarcopenia.40 To gain insight into the effects of aging on
mitochondrial dynamics in skeletal muscle among species, we
assessed key proteins involved in fusion ((mitofusins1 and 2 (Mfn1
and Mfn2)) and fission (fission 1 protein (Fis1) and dynamin-
related protein (Drp1)). Mfn1 levels were significantly upregulated
with age in both mice and rhesus monkeys, with the effect being
most pronounced in the oldest animals, whereas no differences
were detected within the human group (Fig. 6a). Notably, an age-
dependent increase was observed for Mfn2 among all species
Fig. 1 Continued
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(Fig. 6a), implying that fusion is upregulated in skeletal muscle
during aging and that this effect is evolutionarily conserved. These
data are in line with the altered mitochondrial morphology
revealed by transmission electron microscopy (TEM), as illustrated
by the appearance of enlarged mitochondria in muscle of aged
mice and abnormally rounded mitochondria in the muscle of aged
rhesus monkeys (Fig. 2m). While no age-related changes were
observed in fission proteins Drp1 and Fis1 among mice and rhesus
monkeys, a significant increase in Drp1 protein was detected in
elderly humans compared to young (Fig. 6b). Collectively, our data
suggest that a fusion–fission imbalance toward mitochondrial
fusion occurs in aged skeletal muscle.
We next looked at two programs of mitophagy: selective
mitophagy (PINK1/Parkin) and programmed mitophagy (NIX/
BNIP3). The mitochondrially targeted serine/threonine kinase
PTEN-induced putative kinase 1 (PINK1) and the E3 ubiquitin
ligase Parkin are known to selectively promote the degradation of
damaged mitochondria.41 Aside from the downregulated Parkin
protein levels in old rhesus monkeys compared to young, no
significant age-related changes were observed for the PINK1/
Parkin protein levels across species (Fig. 6c). In addition, NIX and
its related family member, Bcl2/adenovirus E1B interacting protein
3 (BNIP3), are unique mitochondria-localized BH3-only proteins
and appear to be able to compensate when the PINK1/Parkin
Fig. 2 Mitochondrial composition is altered with age. Mitochondrial-encoded (ND1-6, CytB, COX1-3, ATP6, and ATP8) and nuclear-encoded
(NDUFAB1, SDHb, SDHd, UQCRC1-2, ATP5a1) mRNA analyzed by quantitative RT-PCR in skeletal muscle of young (Y), middle-aged (M), and old
(O) mice (M) (a–c), rhesus monkeys (Rh) (d–f) and humans (H) (g–i). Relative expression values were normalized to young within each species. j
Citrate synthase activity measured in skeletal muscle of young (Y), middle-aged (M), and old (O) species. k Mitochondrial DNA content
analyzed by quantitative PCR in skeletal muscle of young (Y), middle-aged (M), and old (O) mice, rhesus monkeys and humans. Relative
expression values were normalized to young. Electronic microscopy analysis of skeletal muscle of young (Y), middle-aged (M), and old (O)
mice (l) and rhesus monkeys (m) and the respective mitochondrial area quantification and circularity. Arrows indicate intermyofibrillar
mitochondria; asterisks indicate sarcoplasmic reticulum. Bars equal to 1 µm. n Cellular ATP content from skeletal muscle of young (Y), middle-
aged (M), and old (O) mice and rhesus monkeys. *p< 0.05 vs. young. Values are expressed as mean± SEM
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pathway is deficient. Whereas no age-related alterations were
observed for NIX protein levels across species, BNIP3 protein levels
were reduced in old mice compared to their younger counterparts
(Fig. 6c). In contrast, old rhesus monkeys and humans exhibited
increased BNIP3 protein levels compared to young (Fig. 6c).
Nonetheless, mitophagy seemed not to be significantly altered
overall with age across species, suggesting that damaged
mitochondria are too large, due to increased fusion, to be
engulfed by the autophagosome, favoring the accumulation of
aberrant proteins and damaged organelles. This outcome might
contribute to the reduced age-associated mitochondrial function
observed among species.
Aging provokes increased oxidative stress and inflammation
among species
As mitochondrial oxidative stress is considered a hallmark of
cellular aging, we evaluated age-related effects on oxidative stress
markers in skeletal muscle of mice, rhesus monkeys and humans.
4-hydroxynonenal adducts, a marker of lipid peroxidation, were
increased in skeletal muscle of old mice and humans compared to
young, whereas no age-related effect was detected in the muscle
of monkeys (Fig. 7a). Moreover, an age-related increase was
observed for protein carbonylation in mice and rhesus monkeys,
with the effect being most pronounced in the muscle of older
animals (Fig. 7a). These data collectively indicate that oxidative
stress markers are more prominent with age in mice than in
higher mammals, yet can be observed in some manner in all
species suggesting a possibly conserved phenomenon.
Human aging is characterized by a state of chronic low-grade
inflammation, designated as ‘‘inflamm-aging’’.24, 42 An increased
transcript level in the pro-inflammatory cytokine interleukin 6 (IL-
6) was observed in skeletal muscle of old mice (Fig. 7b). In the
skeletal muscle of rhesus monkeys, an age-related upregulation of
tumor necrosis factor-α (TNF-α) and IL-6 expression was observed
with age; similar effects were observed in skeletal muscle of
humans (Fig. 7b). Among all species, skeletal muscle exhibited
elevated expression levels of anti-inflammatory IL-10 with age
(Fig. 7b). In addition, we looked at the NF-κB transcription factor,
as it is a master regulator of inflammation through its ability to
Fig. 2 Continued
Conserved and species-specific
EM Mercken et al.
7
Published in partnership with the Japanese Society of Anti-Aging Medicine npj Aging and Mechanisms of Disease (2017)  8 
Fig. 2 Continued
Conserved and species-specific
EM Mercken et al.
8
npj Aging and Mechanisms of Disease (2017)  8 Published in partnership with the Japanese Society of Anti-Aging Medicine
induce transcription of pro-inflammatory genes.43 The ratio of
phospho-active to total NF-κB was not affected with age in
skeletal muscle of mice, while a decrease in active NF-κB levels
was observed in muscle of old monkeys compared to young
(Fig. 7c). In line with the upregulation of pro-inflammatory
cytokines with age in human skeletal muscle, an age-induced
up-regulation of active NF-κB protein levels was observed
(Fig. 7c). The increased inflammatory response in aged human
skeletal muscle is further evidenced by the increased
cyclooxygenase-2 (COX2) expression with age44 (Fig. 7d). These
observations suggest that the skeletal inflammatory profile differs
with age between species, but appears to be most pronounced in
humans.
Deregulated nutrient-sensing signaling pathway across species
The IGF-AKT-mTOR axis is a well-known conserved signaling
pathway in aging that is involved in protein synthesis.1, 45 As a
read out of protein turnover, we measured AKT and its main up-
stream and down-stream effectors in skeletal muscle. We
observed that AKT activation was downregulated in skeletal
muscle of old mice, as lower phosphorylated AKT levels were
detected by western blot analysis (Fig. 8a). Interestingly,
phosphorylated AKT was increased in middle-aged monkeys,
whereas in humans, a tendency toward increased AKT activation
was seen with age (Fig. 8a). Among the downstream effectors of
AKT, pGSK3ß, and pFOXO1 protein levels were lower in skeletal
muscle of old mice, suggesting increased protein degradation
Fig. 2 Continued
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with age (Fig. 8b, c). In skeletal muscle of monkeys and humans,
pGSK3ß levels were unaltered with age, whereas similar to mice,
reduced pFOXO levels were observed in the older human cohort
(Fig. 8b, c). These data are supportive of the IPA, showing that the
mTORC1 complex is upregulated in monkeys and humans, yet
downregulated in mice with age (Fig. S3). Of note, the mTORC2
complex, known to regulate cytoskeletal organization and cell
survival/metabolism, was upregulated with age in all species (Fig.
S3).26 Two key downstream targets of the mTORC1 complex, S6
kinase (S6K) and the eukaryotic translation initiation factor
4E–binding protein (4E-BP), which both play important roles in
the initiation of mRNA translation, were unchanged with age in all
species (Fig. S3).46 However, many of the translation components,
such as the eIF4A-binding protein, were increased in the old group
in all species (Fig. S3). Upstream effectors of AKT, such as IRS1/2,
were downregulated in all species with age, whereas IGF-1 is
downregulated in mice and humans, but is unchanged in
monkeys (Fig. S4). Unlike the other molecular denominators of
aging described above, within the nutrient sensing pathways,
there are important similarities, but also significant differences
among species with age.
DISCUSSION
In the studies presented herein, we compared a collection of
molecular and biological end-points among multiple mammalian
species, i.e., mice, rats, rhesus monkeys, and humans, at
comparable ages along the trajectory of their respective lifespans.
Our analysis has uncovered several species-unique and generally
conserved features of mammalian aging. Of particular note, we
observed the involvement of four of the nine ‘‘Hallmarks of
Aging’’1 in each of the mammalian species studied herein:
mitochondrial dysfunction, oxidative stress, inflammation, and
nutrient-sensing pathways.
In terms of body composition, we observed significant
changes with age. In particular, we saw an age-related increase
in bodyweight in all species. However, the reason behind the
increase was different among the species. Specifically, uniquely in
mice, bodyweight increased due to an increase in lean mass, while
fat mass was lower in the older animals. Conversely, in rats,
monkeys and humans, the increase in bodyweight stemmed from
an increase or no change in fat mass, while lean mass decreased
with advancing age (results herein and).30, 47, 48 The unique
feature of mice raises caution about the use of this model
organism in understanding many age-related diseases, but
particularly those involving metabolic processes.
Notably, our array studies identified only two “pathways” that
were downregulated in the species studied herein: the mitochon-
drial ETC and OXPHOS. Previous transcription profiles of aging in
the skeletal muscle of worms, flies, mouse, rats, and humans also
indicate that genes encoding mitochondrial components decrease
with age.31, 49, 50 Thus, research over the last decade has
commonly found an association between mitochondrial dysfunc-
tion and major phenotypes associated with aging, including
muscle decline. Importantly, mitochondrial transcript levels of
humans appeared the most preserved, at least until middle age,
likely suggesting an evolution-driven fitness more robust than
other species. That said, the observed species-specific alterations
in gene expression emphasize the importance of studying aging
in humans in order to understand the mechanisms that modulate
life- and health-span in people.
Coordination of expression of the nuclear and mitochondrial
genomes is crucial for optimal organism function, and studies
have found that this coordination is disturbed with age.51, 52 In
general agreement with prior work,51 our analysis revealed
discoordination between the regulation of the mitochondrial
and nuclear genomes. Specifically, we observed downregulation
of the mitochondrial-encoded genes in all species with age,
Fig. 3 OXPHOS complexes remain unchanged in rat skeletal muscle with age. a Protein complexes from young (Y), middle-aged (M), and old
(O) rat skeletal muscle tissue were isolated by blue-native electrophoresis and stained with Coomassie (left panel) or detected on a 1D BN
western blot (right panel). Panels show a representative set of young, middle-aged and old tissue out of 15 samples (five individuals in each
group). b Densitometric quantification of 1D BNE western blots. Signals of complexes and supercomplexes containing mitochondrial encoded
subunits were normalized to complex II not containing mitochondrial encoded subunits (n= 5). Assignment of complexes: S, supercomplexes
containing complex I, III, and IV with the stoichiometry of I1III2IV0–4; III2, dimer of complex III or cytochrome c reductase; IV, complex IV or
cytochrome c oxidase; V, complex V, or ATP synthase
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although the timing, middle-age or old, was different among
species. Overall, the results regarding the expression patterns of
the nuclear and mitochondrial genomes at oldest ages are
consistent with impaired compartment coordination and likely
reflect the observed mitochondrial dysfunction.
OXPHOS component analysis uncovered that muscle extracts
from old rhesus monkeys and humans contained an aberrant
composition of several of the mitochondrial membrane respira-
tory complexes, including a tendency towards a decrease in the
supercomplexes with age (although rats did not exhibit this
phenotype). In addition, despite the fact that there was species-
specific variability in some of the individual parameters, our
studies revealed an age-related reduction in mitochondrial
content in all species, as assessed by citrate synthase (CS), mtDNA,
and TEM experiments, implying an underlying role for mitochon-
drial dysfunction in the aging process. These findings agree
well with the recent work of Ikeda et al.15, who reported that
in mice mitochondrial activity is impaired and ATP content
decreased due to a lack of supercomplex formation. Notably, a
previous study using primary skin fibroblasts from long-lived
individuals (centenarians) found that supercomplexes were
increased, possibly as a compensatory mechanism to facilitate
efficient respiratory chain activity.53 It is likely that this apparent
discrepancy represents adaptation changes that are not seen in
the old of the cohort studied herein, but that are unique to
centenarians.
Mitochondrial morphology is altered during aging in a process
governed by the fission and fusion machinery. In our studies, we
observed that fusion is increased in all species with age (as
evidenced by the higher protein levels of Mfn1/Mfn2 relative to
younger controls), whereas fission shows variable and limited
differences. An imbalance in mitochondrial dynamics towards
fusion is associated with the appearance of abnormal mitochon-
dria, including those that are enlarged or more rounded in shape,
as seen by TEM in mouse and monkeys, respectively. This
hyperfusion phenotype may stem from an attempt to cope with
an increase in mtDNA mutations by dilution,54 creating giant
mitochondria in the process that are unable to be efficiently
removed by the autophagosome. Our observation that there are
no consistent changes in mitophagy with age in any of the species
suggests that while this system may remain intact, it is incapable
of dealing with the hyperfusion network, ultimately resulting in
mitochondrial dysfunction. We note that prior evidence has
revealed a decline in the autophagic process during normal aging
in invertebrates and higher organisms.55
Additionally, we measured a gradual increase in oxidative stress
markers over the lifespan of all species. This finding is by-and-
large consistent with prior studies that have indicated an increase
in oxidative macromolecular damage with age, presumably
resulting from aberrant mitochondrial activity.56, 57 Thus, our
collective studies support that with age, mitochondrial damage
progressively increases, leading to altered mitochondrial composi-
tion and morphology, which further exacerbates the mitochon-
drial dysfunction and promotes increased fusion as a
compensatory mechanism for the consequent ATP demands.
Another notable feature of our analysis was the increase in
variable inflammatory markers with age in all species. Inflamm-
aging was most pronounced in humans, involving a unique age-
related upregulation of the transcription factor NF-κB as previously
shown.58 It is tempting to speculate that the distinct inflammatory
responses among the different species stems at least in part from
the fact that humans exist in an environment accompanied by
Fig. 4 Aged skeletal muscle displays a decrease in OXPHOS complexes in primates. a Protein complexes from young (Y), middle-aged (M), and
old (O) skeletal muscle from rhesus monkeys were isolated by blue-native electrophoresis (BNE) and stained with Coomassie (left panel) or in-
gel complex I activity stain (right panel). Panels show a representative set of young, middle-aged, and old tissue out of 12 samples (four
individuals in each age group). b Western blot detection of OXPHOS complexes and supercomplexes in 1D BN-blots using specific antibodies
against complex I, II, III, IV, and V. c Densitometric quantification of in-gel activity stain (A, right panel) expressed as % of young complex I
containing supercomplexes in four individuals each group. d Densitometric quantification of 1D BNE western blots. Signals of complexes and
supercomplexes containing mitochondrial-encoded subunits were normalized to complex II not containing mitochondrial-encoded subunits
(n= 4). e Protein complexes and subunit composition by 2D BN/SDS PAGE shown as silver stain from young (left panel), middle-aged (middle
panel), and old (right panel). Assignment of complexes: S0, supercomplexes containing complex I and III with the stoichiometry of I1III2; S1,
supercomplexes containing complex I, III, and IV with the stoichiometry of I1III2IV1; S, supercomplexes containing complex I, III, and IV with the
stoichiometry of I1III2IV0–4; III2, dimer of complex III or cytochrome c reductase; IV, complex IV or cytochrome c oxidase; V, complex V or ATP
synthase. f Skeletal muscle cardiolipin content (L4/L3O ratio) in subsarcolemmal (SS) and inter-myofibrillar (IMF) mitochondrial fraction from
young (Y), middle-aged (M) and old rhesus monkeys. L4: tetra linoleoyl-cardiolipin, L3O: trilinoleoyl-oleoyl-cardiolipin. *p< 0.05 vs. young.
Values are expressed as mean ± SEM
Fig. 5 Patterns of changes in OXPHOS complexes in human skeletal muscle with age. a Protein complexes from young (Y), middle-aged (M),
and old (O) human skeletal muscle tissue were isolated by blue-native electrophoresis and stained with Coomassie (left panel), detected on a
1D BN western blot (middle panel) and in-gel complex I activity stain (right panel). Panels show a representative set of young, middle-aged, and
old tissue out of 9 samples (three individuals in each group). b Densitometric quantification of 1D BNE western blot (n= 3). Assignment of
complexes: S, supercomplexes containing complex I, III and IV with the stoichiometry of I1III2IV0–4; III2, dimer of complex III or cytochrome c
reductase; IV, complex IV or cytochrome c oxidase; V, complex V or ATP synthase
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unique exposures and lifestyles, including a widespread contact
with antigenic elements. Our results, therefore, indicate that in
addition to oxidative stress and mitochondrial dysfunction,
inflammation plays a significant role in the aging process, as
previously proposed.59, 60
An additional element that we observed during our analysis is
the likely involvement of the nutrient sensing pathways in the
aging phenomenon. Associations have been previously intro-
duced between mitochondrial aging and the IGF-1 signaling and
mTOR pathway.61, 62 One notable observation of our study
Fig. 6 Mitochondrial dynamics and mitophagy are altered in an age-dependent manner. Immunblot of a fusion (Mfn1 and Mfn2), b fission
(Fis1 and Drp1), and c mitophagy (PINK1, Parkin, NIX, and BNIP3) proteins in skeletal muscle of young (Y), middle-aged (M), and old (O) mice,
rhesus monkeys and humans. Values are expressed as mean± SEM. *p< 0.05 vs. young
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was the deregulated AKT response with age. In mice, the AKT
response, as measured by phosphorylated AKT, was found to be
downregulated, as was mTORC1, indicating a favoring of protein
degradation, consistent with the increased GSK3β and FOXO1.
Conversely, in humans, the AKT response was generally upregu-
lated, revealing species-specific alterations during aging. Based on
our IPA, we surprisingly observed that mTORC1 was upregulated
in humans and monkeys, indicating that protein synthesis may be
promoted as a consequence of the aging process. It is possible
that the age-related muscle atrophy in primates is accompanied
by a compensatory response that attempts to retain muscle
integrity, but fails due to impaired cellular function, as suggested
by a previous study.63 Our data in total paints a picture in which
age-dependent alterations in oxidative stress, inflammation, and
the nutrient signaling pathways ultimately affect the quality and
status of mitochondria.
Notably, the age-related mitochondria impairment also affect
energy metabolism leading to the alteration of beta-oxidation
Fig. 6 Continued
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with an increase of intra-fibers lipid accumulation that affects
skeletal muscle quality and function, as previously shown both in
human and denervation-induced atrophy in mice model.64, 65
The current work highlights the molecular denominators of
aging process among different mammalian species, including
humans, with different lifespan. Mitochondria and their status are
at the core of commonalities tightly related to evolution
constrains such as natural selection and fitness, but also effects
of environments/life style and food intake. Not surprisingly, many
mutations that extend lifespan in animal model affect signaling
pathways regulating the metabolicrate and human longevity is
associated with efficient respiratory chain activity and mitochon-
drial genetics.53, 66
Fig. 7 Increased oxidative stress and inflammation are observed with age among species. a Oxidative stress markers (4-HNE and protein
carbonylation) in skeletal muscle of mice (M), rhesus monkeys (Rh), and humans (H). b Inflammatory mRNA markers (TNF-α, IL-1β, IL-6, and IL-
10) analyzed by quantitative RT-PCR in skeletal muscle of mice (M), rhesus monkeys (Rh), and humans (H). Relative expression values were
normalized to young within each species. c Immunoblot of pNF-κB and NF-κB in skeletal muscle of young (Y), middle-aged (M), and old (O)
mice, rhesus monkeys and humans. d Immunoblot of COX2 in human skeletal muscle of young (Y), middle-aged (M), and old (O) individuals.
*p< 0.05 vs. young. Values are expressed as mean± SEM. *p< 0.05 vs. young
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An important challenge looking forward is the development of
therapeutic strategies that improve mitochondrial function as a
means to delay the onset of age-related diseases, keeping in mind




Young, middle-aged, and old male skeletal muscle samples from
C57BL/6 mice, Fisher-344 rats, rhesus monkeys (Macacamulatta),
and humans were used in this study. Study species characteriza-
tions can be found in Table 1. C57BL/6J mice were obtained from
the Jackson Laboratory (Bar Harbor, ME, USA) and housed at the
Gerontology Research Center (Baltimore, MD, USA). Mice were
housed in cages of four with ad libitum access to diet and tap
water. Mice were fed house chow (HarlanTeklad Global 18%
Protein Rodent Diet, Harlan Teklad, Madison, WI). Rats were fed a
NIH-31 standard chow (Harlan Teklad, Indianapolis, IN, USA) and
were singly housed in an environmentally controlled vivarium
with unlimited access to water. Animal rooms were maintained at
20–22 °C with 30–70% relative humidity and a 12-hour light/dark
cycle according to animal protocols and NIH guidelines. Gastro-
cnemius and vastus lateralis muscles were harvested from mice
and rats, respectively. Rhesus monkeys were housed continuously
at the NIH Animal Center, Poolesville, MD. Monkeys were housed
individually in standard nonhuman primate caging on a 12 h light/
12 h dark cycle, room temperature 25.5 ± 0.5 °C, humidity at 60 ±
20%. Monkeys were maintained on standard monkey chow
(TestDiet® #5038 Purina Mills, Richmond, IN). They received two
meals per day at estimated ad libitum levels throughout the study
and water was always available. Monkeys were monitored
minimally three times daily by trained animal care staff. Biopsies
of the vastus lateralis were obtained from the monkeys from
ongoing NIA studies. All animal procedures for this study were
reviewed and approved by the Animal Care and Use Committee
(ACUC) at the Biomedical Research Center (NIA/NIH).Humans who
underwent surgery for hip dysplasia were included in this study.
During surgery, biopsies from the vastus lateralis muscle were
obtained. Age (>20 years) and ability to provide informed consent
cooperating with study personnel were inclusion criteria, while
exclusion criteria were presence of diseases, i.e., chronic kidney
and/or liver diseases, bleeding disorders, severe type 2 diabetes,
rheumatic diseases, osteoarthritis, neuromuscular disorders, malig-
nancies and systemic infections, other than chronic steroid use,
Fig. 7 Continued
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major psychological problems or history of alcohol or drug abuse,
evidence of prior surgery in the involved hip. Written informed
consent was obtained from each patient before the kick off study.
A thorough medical history, including smoking habits and alcohol
consumption, occupation and level of physical activity was taken
from each patient and reported in questionnaire forms. Written
informed consent was obtained from all participants, and the
study was approved by the ethics committees of Istituto
Ortopedico Rizzoli and Sant’Orsola-Malpighi University Hospital
(Bologna–Italy). With the exception of tissues processed for
electron microscopy, muscle samples for all study species were
flash frozen in liquid nitrogen and stored at −80 °C until assayed.
Gastrocnemius (mice) and vastus lateralis (rat, monkey, human)
muscles were used for all biochemical assays and to generate the
micro-array data.
Body composition
Mice and rats. Measurements of lean, fat, and fluid mass in live
mice and rats were acquired by nuclear magnetic resonance using
the Minispec LF90 (Bruker Optics, Billerica, MA, USA). In addition, a
different set of mice were euthanized and lower leg muscles
(soleus, plantaris, gastrocnemius, tibialis, and extensor digitorum
longus muscles) were collected with standardized dissection
methods, cleaned of excess fat and tendon/connective tissue, and
pair weighed on an analytical balance. Rhesus monkeys. Monkeys
Fig. 8 Nutrient-sensing signaling pathway is deregulated across species with age. Immunoblot of a pAKT1/2 and AKT1/2 b pGSK3β and GSK3
c pFOXO1 and FOXO in skeletal muscle of young (Y), middle-aged (M), and old (O) mice, rhesus monkeys, and humans. *p< 0.05 vs. young.
Values are expressed as mean ± SEM. *p< 0.05 vs. young
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were anesthetized after an overnight fast using either Ketamine
(7–10mg/kg, IM) or Telazol (3–5mg/kg, IM). Total body scans were
acquired with the monkey in a supine position using dual-energy
X-ray absorptiometry (DEXA) Lunar Prodigy X-Ray Bone Densit-
ometer (Madison, WI). Data analysis was done with GE encore
Software v.12.3. Humans. Standing height and weight were
measured for each participant. Muscle thickness of the vastus
lateralis was measured by a portable ultrasound instrument
(Mylab25, Esaote, Genova, Italy). Thickness measure was obtained
as vertical distance between muscle superficial and deep
aponeuroses at an equidistant point from right and left borders
of the sagittal image.
Real Time -quantitative PCR and mtDNA analysis
Total RNA was isolated from frozen muscle samples by Trizol
(Invitrogen, NY, USA) and first strand complementary DNA (cDNA)
was synthesized using the High Capacity cDNA Reverse Transcrip-
tion Kit (Applied Biosystems, Austin, TX) following the manufac-
turer’s instructions. Quantitative real-time PCRs were performed
with SYBR® Green PCR master mix to observe expression of
desired genes on an ABI Prism 7300 sequence detection kit
(Applied Biosystems). Quantification was performed using the
ΔΔCT method after normalization to the housekeeper gene
glyceraldehyde 3-phosphate dehydrogenase (Gapdh) or β-actin.
Each analyzed sample was performed in three replicates. Fidelity
of the PCR was determined by melting temperature analysis. Total
DNA was extracted with DNeasy blood and tissue kit (QIAGEN,
Valencia, CA). In mice, mtDNA was amplified using primers specific
for the mitochondrial cytochrome c oxidase subunit 2 (COX2)
gene and normalized to genomic DNA by amplification of the
ribosomal protein s18 (rps18) nuclear gene. In addition, mtDNA
was amplified using primers specific for mitochondrial NADH
subunit 1 (rhesus monkeys) and ND1 (humans) gene and
normalized to genomic DNA by amplification of β-actin nuclear
gene. Oligonucleotides used for real-time RT-quantitative PCR are
listed in Table S1.
Microarray data analysis
RNA was isolated from skeletal muscle of mice, rats, rhesus
monkeys, and humans at different ages using Trizol Reagent
(Invitrogen, Carlsbad, CA) following the manufacturer’s instruc-
tions. RNA was then hybridized to: Mouse, IlluminaMouseRef-8;
Rat, Illumina Rat Ref-12; Monkey, Sentrix Human HT-12; Human,
Illumina Human HT-12 Expression BeadChips (Illumina, San Diego,
CA) following manufacturers protocols. Raw data were subjected
to Z normalization to ensure compatibility using the formula: z
(raw data) = [ln (raw data)—avg(ln(raw data))]/[stddev(ln (raw
data))], where ln is natural logarithm, avg is the average over all
genes of an array, stddev is the standard deviation over all genes
of an array.67 The Z ratio (between treatment A and B) is given by
z(A)−z(B)/std dev. Individual genes with Z ratio > 1.5, p-value <
0.05, and avg intensity > 0 were considered significantly changed.
For PAGE, a list of pathways was obtained from http://www.
broad.mit.edu/gsea/msigdb/msigdb_index.html (C2 collection).
Our expression data was tested for gene set enrichment using
the PAGE method as previously described.32 Briefly, for each
pathway a Z score was computed as Z (pathway) = (sm mu)*pow
(m,0.5)/delta, where mu =mean Z score of all gene symbols on the
microarray, delta = standard deviation of Z scores of all gene
symbols on the microarray, sm =mean Z score of gene symbols
comprising one pathway present on the microarray, and m = no of
gene symbols in a pathway present on the microarray. For each Z
(pathway) a p-value was also computed in JMP 6.0 to test for the
significance of the Z score obtained. These tools are part of DIANE
6.0 and are described at http://www.grc.nia.nih.gov/branches/rrb/
dna/diane_software.pdf. In addition to pathway PAGE analysis
described above, statistically significant gene results were
analyzed using IPA (www.analysis.ingenuity.com; Ingenuity Sys-
tems, Redwood City, CA, USA) to identify the top comparative
aging network functions. Gene expression data was deposited in
NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/
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Western blotting
Tissues were lysed in radio immunoprecipitation buffer supple-
mented with ethylenediaminetetraacetic acid and ethylene glycol
tetraacetic acid (Boston BioProducts, Ashland, MA) and protease
and phosphatase inhibitors (Sigma Aldrich, St Louis, MO).
Following centrifugation (14,000 rpm, 30 min at 4 °C) protein
concentration was quantified using the Bradford assay method
(Bio-Rad, Hercules, CA). Proteins were separated by sodium
dodecyl sulfate polyacrylamide gel electrophoresis under reducing
conditions and then transferred to nitrocellulose membranes.
Western blots were performed according to standard methods.
Membranes were blocked in 5% nonfat milk, incubated with the
antibody of interest followed by incubation in a secondary
antibody conjugated with horseradish peroxidase. Immunoreac-
tive bands were visualized using chemiluminescent (ECL) Plus
western blotting detection system (GE Healthcare, Pascataway,
NJ), Immobilon Western Chemiluminescent HRP Substrate (Milli-
pore, Billerica, MA), or SuperSignal West Femto Maximum
Sensitivity Substrate (Thermo Scientific, Waltham, MA). The
quantification was performed by volume densitometry using
ImageJ software and normalized to staining with Ponceau S
solution or anti-β-tubulin (both from Sigma-Aldrich, St. Louis, MO),
which served to verify equal protein loading. The primary
antibodies used in this study were directed against Mfn1, Mfn2,
Drp1, and Fis1 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA),
PINK1 (Novus Biologicals, Littleton, CO), Parkin, pNF-κB, AKT, pAKT
(Ser473), FOXO, pFOXO, GSK-3β, and pGSK-3β (Cell Signaling
Technology, Inc., Danvers, MA), BNIP-3 (Sigma Aldrich), NIX, COX2
(Abcam Inc., Cambridge, MA), 4HNE (EMD Calbiochem, La Jolla,
CA) and NF-κB (Epitomics, Inc., Burlingame, CA), which were
generally used at the manufacturer’s recommended dilution. For
detection of protein NF-κB levels in humans, rabbit monoclonal
C22B4 anti-NF-κB (Cell Signaling) was used. Protein carbonylation
was measured using an oxyblot protein oxidation kit (Millipore,
Billerica, MA) according to the manufacturer’s instructions.
Sample preparation and BNE
Preparation of crude mitochondrial membranes and solubilization
of mitochondrial membrane protein complexes were performed
as previously described.68 Briefly, skeletal muscle samples from
rats, rhesus monkeys and humans were weighed and finely
minced with scissors. The minced tissue was homogenized in 250
mM Sucrose, 10mM Tris-Cl pH 7.5, 2 mM 6-aminohexanoic acid
using a pre-cooled motor-driven, tightly fitting glass/Teflon Potter-
Elvehjem homogenizer. Aliquots corresponding to 30 mg wet
weight were centrifuged 10min at 10,000×g. Pellets were frozen
in liquid nitrogen and stored at −80 °C. In order to solubilize
protein complexes, aliquots were resuspended in 50 mM NaCl, 50
mM imidazole pH 7, 2 mM 6-aminohexanoic acid and solubilized
by adding 10 µl digitonin (20% stock in water (w/v)). Samples were
centrifuged for 20 min at 22,000×g and the protein content of the
supernatant was measured. Equal amounts of protein/lane (50 µg/
sample for Complex I (CI) in-gel activity stain and native blot; 75 µg
for Coomassie stain) were mixed with a 5% Coomassie blue G-250
dye stock suspension to obtain a detergent/dye ratio of 8/1. Blue
native electrophoresis was performed as described.68 Due to the
limited sample size of the human samples BNE was performed in
mini format as previously described.69 Equal amounts of protein/
lane (10 µg/sample for CI in-gel activity stain and native blot; 15 µg
for Coomassie stain) were loaded.
Two-dimensional (2D) BN/SDS page
Following separation of mitochondrial OXPHOS complexes by
BNE, subunit composition was studied using 2D BN/sodium
dodecyl sulfate-polyacryl amide gel electrophoresis as described
in ref. 68. Briefly, one-dimensional (1D) BN-strips were soaked in
1% SDS for a few minutes and a SDS-gel was casted below. 1D
strips were pushed on top of the 2D gel and SDS electrophoresis
was performed at room temperature. Gels were silver-stained.70
1D BN western blotting
Native protein complexes were transferred to a Polyvinylidene
difluoride membrane using an electroblotting buffer composed of
50mM Tricine, 7.5 mM imidaziol for 3–4 h at room temperature,
voltage set to 20 V and current limited to 0.5 mA/cm2 (ref. 68).
Blots were sequentially decorated with a monoclonal mouse
antibody against a complex I subunit NDUFB8 (Invitrogen) and
polyclonal rabbit antiserum against subunits of OXPHOS com-
plexes III, V, IV, and II (in that order). Immunoreactive bands were
visualized by ECL chemiluminescence and detected by a
ChemiDoc XRS device (Bio-Rad). Densitometric quantification of
samples from rats and rhesus monkeys was performed by
Quantity One software package (Bio-Rad). Densitometric quanti-
fication of human samples was performed by AIDA image analyzer
software package (Raytest).
Coomassie stain of 1D BN-gels
Gels were fixed in 50% methanol, 10% acetic acid and stained with
0.025% Coomassie G250 (Serva) in 10% acetic acid. Following
destaining in 10% acetic acid gels were scanned by an office flatbed
scanner (Epson perfection 2400 PHOTO) for documentation.
Complex I in-gel catalytic activity stains
In gel activity stain was used to quantify complex I containing
supercomplexes isolated by 1D BNE. The in-gel NADH: nitrote-
trazolium blue (NTB) reductase assay followed essentially the
protocols described by Zerbetto et al.71 with some modifications
according to Wittig et al.72. Briefly, complex I in-gel activity stain
was done in 1D BN-gels directly after electrophoresis. 1D BNE gels
were incubated in buffer containing 5mM Tris/HCl, pH 7.4, 0.1 mg/
ml NADH and 2.5 mg/ml NTB until the purple colour was
developed (approx. 30 min). Reaction was stopped with 50%
methanol, 10% acetic acid fixing solution for several hours to
remove Coomassie. Gels were placed into water and scanned for
further densitometric analysis by the Quantity One Software (Bio-
Rad).
Citrate synthase activity
Citrate synthase activity was determined in approximately 20 µg
of protein lysates following the method described by Bernier
et al.73 Citrate synthase were determined by spectrophotometric
methods. Results were expressed in nmol/mg protein/min.
Cardiolipin
SS and IMF mitochondria were isolated as previously described.74
The isolated pellets were suspended in 100 ul of Reagent C from
the Mitochondria Isolation Kit (Abcam Inc., Cambridge, MA) and
frozen at −80 °C. Isolated mitochondria were extracted using a
previously described method.75 Briefly, to 80 μl of the suspension,
320 μl of water was added and mixed. Ten microliter of 1 mg/ml of
myristoyl-cardiolipin was added as internal standard. Two milliliter
of a chloroform:methanol (2:1) mixture was added and the
aqueous layer was removed. Four hundred microliter of water was
added twice to the organic phase and removed. The samples were
then subjected to silica gel chromatography and the lipid classes
were eluted in solvents with increasing polarity: (95:1 (Isooctane:
EtOAc); 20:1 (Isooctane:EtOAc); 75:25 Isooctaine:EtOAc; 75:25:2
(Isooctane:EtOAc:glacial acetic acid); 75:25:2 (Isooctane:EtOAc:
glacial acetic acid). The phospholipids were eluted in the final
step with 4 ml of methanol, stream dried, and then reconstituted
again in 250ml of methanol. MS/MS analysis was performed using
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a triple quadrupole mass spectrometer model API 4000 system
from Applied Biosystems/MDS Sciex equipped with Turbo Ion
Spray® (TIS) (Applied Biosystems, Foster City, CA, USA). The data
was acquired and analyzed using Analyst version 1.4.2 (Applied
Biosystems). Negative electrospray ionization data were acquired
using multiple reaction monitoring (MRM). The TIS instrumental
source settings for temperature, curtain gas, ion source gas 1
(nebulizer), ion source gas 2 (turbo ion spray), and ion spray
voltage were 500 °C, 20 psi, 60 psi, 60 psi, and −4500 V, respec-
tively. The TIS compound parameter settings for declustering
potential, entrance potential, and collision cell exit potential were
−110—10 V, and −6 V, respectively. The collision energy setting
was −50 V for cardiolipin molecular species and −75 V for
myristoylcardiolipin. The MRM transitions were (C18:2)4-CL
(1448/695.0); (C18:2)3(C18:1)-CL(1450/695.0), and myristoyl-CL
(1240/227.3). The chromatographic experiments were carried out
on a Shimadzu Prominence HPLC system (Shimadzu, Columbia,
MD, USA) following a previously described protocol, with slight
modifications.75 Briefly, the samples were introduced to the
analytical column using Shimadzu SIL-20A autosampler and
maintained at 4 °C in the autosampler tray, and injections of
30 μl were made with a column temperature of 35 °C. The
separation of (C18:2)4-CL, (C18:2)3(C18:1)-CL and (C18:2)2(C18:1)
2-CL was accomplished using a Symmetry C18 column
(150 × 3.9 mm ID, 5 μ). The mobile phase consisted of 90:10
acetonitrile:water containing 0.5% of trimethylamine and 0.5% of
glacial acetic acid as Component A and 90:10 isopropanol:water
containing 0.5% of trimethylamine and 0.5% of glacial acetic acid
Component B. A linear gradient was run as follows:0 min 0% B;
5 min 0% B; 70 min 100% B; 80 min 100% B; 85min 50% B at
0.4 ml/min. The total run time was 90min per sample.
ATP analysis
ATP content was measured with a commercial kit according to the
manufacturer’s instructions (Abcam Inc., Cambridge, MA).
Electron microscopy
For TEM analysis, gastrocnemius, and vastus lateralis samples from
mice and rhesus monkey, respectively, were removed and placed
directly into a fixative solution consisting of 2.5% glutaraldehyde
and 3% paraformaldehyde in 0.1 M sodium cacodylate buffer
(Electron Microscopy Sciences, Hatfield PA). The tissues were post
fixed in 1% osmium tetroxide for 1 h at 4 °C in the same buffer,
dehydrated and then embedded in Embed 812 resin (Electron
Microscopy Sciences, Hatfield PA), after which tissue samples were
transferred to pure resin for 24 h. Blocks were formed in fresh resin
contained in silicon molds, and the resin was allowed to
polymerize for 48 h at 65 °C. Ultrathin sections were obtained
and stained with uranyl acetate and lead citrate, and then
examined on a Philips CM-10 electron microscope (ServicioCen-
tralizado de Apoyo a la Investigación, SCAI, University of Córdoba,
Spain) at 25,000x magnification by a blinded investigator. Ten
digital images per sample were analyzed using NIH Image J (NIH,
USA) software for measurement of mitochondrial area and
mitochondrial circularity.
Statistics
Data are expressed as means ± standard error of the mean (SEM).
Between-group comparisons were analyzed using the Student’s t-
tests are Mann–Whitney U-test when normality assumption
was not obtained. Analyses were performed using Excel 2010
(Microsoft Corp., Redmond, WA). A p-value of ≤0.05 was
considered statistically significant.
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